Cholesterol, Elevated
14
1
3
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (14)
Impact of Phytosterol-Rich Extract on Lipid Profile
Investigating The Potential Of A Hay-Aged Cheese To Reduce Cholesterol As Mediated By Changes In The Gut Microbiome
Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH)
Effects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonists
Statin Reminders for Improving Prescribing in Primary Care
Unravelling the Impact of Diet on Cardiovascular Health in Heterozygous Familial Hypercholesterolemia.
A Pilot Study to Explore the Role of Gut Flora in Elevated Cholesterol
Community Intervention to Improve CVD Risk Factor Control in Young American Indians
Unravelling the Impact of Diet on Cardiovascular Health in Treated Heterozygous Familial Hypercholesterolemia.
Effect of a Customised Lifestyle Medicine Strategy on Lowering Blood Lipid Levels in Indian Physicians
Peer-delivered and Technology-Assisted Integrated Illness Management and Recovery
Long-term Consumption of Resistant Starch Type-4 (RS4)
Daily Blood Glucose Trends in Patients at Risk for Diabetes
Empowering Immigrant Women for Active and Healthy Lifestyle